Short Interest Worth Mentioning: CEREBAIN BIOTECH CORPORATION NEW (OTCMKTS:CBBT) Has Decline in Shorts

November 28, 2016 - By Ruchi Gupta   ·   0 Comments

Short Interest Worth Mentioning: CEREBAIN BIOTECH CORPORATION NEW (OTCMKTS:CBBT) Has Decline in Shorts

The stock of CEREBAIN BIOTECH CORPORATION NEW (OTCMKTS:CBBT) registered a decrease of 4.76% in short interest. CBBT’s total short interest was 2,000 shares in November as published by FINRA. Its down 4.76% from 2,100 shares, reported previously. With 1,700 shares average volume, it will take short sellers 1 days to cover their CBBT’s short positions. The stock last traded at $0.78 per share. It is down 100.00% since April 25, 2016 and is uptrending. It has outperformed by 93.99% the S&P500.

Cerebain Biotech Corp. is a biomedical company. The company has a market cap of $5.62 million. The Firm operates as a development-stage medical device firm focused on the creation and clinical development of a minimally invasive implantable device. It currently has negative earnings. The Company, through its subsidiary, Cerebain Operating, Inc., is involved in the discovery of products for the treatment of Alzheimer’s disease utilizing Omentum.

CBBT Company Profile

Cerebain Biotech Corp., incorporated on December 18, 2007, is a biomedical company. The Firm operates as a development-stage medical device firm focused on the creation and clinical development of a minimally invasive implantable device.

More notable recent Cerebain Biotech Corp (OTCMKTS:CBBT) news were published by: Businesswire.com which released: “Cerebain Biotech Presents Update on Its Medical Device Research and …” on September 13, 2016, also Businesswire.com with their article: “Cerebain Biotech Announces Business Relocation into the Heart of Orange County …” published on May 04, 2016, Businesswire.com published: “CORRECTING and REPLACING Cerebain Biotech Today Announced It Plans to Seek FDA …” on April 27, 2016. More interesting news about Cerebain Biotech Corp (OTCMKTS:CBBT) were released by: Businesswire.com and their article: “Discount Dental Materials, Inc. Changes Its Name to Cerebain Biotech Corp.” published on June 19, 2014 as well as Businesswire.com‘s news article titled: “Cerebain Biotech Announces Next Phase as It Continues to Wage War against …” with publication date: April 09, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Ruchi Gupta


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>